跳至主要内容
临床试验/NCT04098510
NCT04098510Unknown不适用

Concentration of Mitoquinone Mesylate in Skeletal Muscle After a Single Oral Dose of MitoQ

University of Copenhagen1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年9月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
10
试验地点
1
主要终点
Muscle mitoquinone mesylate concentration

研究概览

简要总结

The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 18-40 years of age

排除标准

  • Previous use of MitoQ or CoQ-10 within 30 days of screening appointment
  • Ongoing use of MitoQ
  • Ongoing treatment with medications
  • Disease deemed by the MD to infer a risk to participate in the trial

研究组 & 干预措施

MitoQ

Experimental

Subjects ingest 160 mg of MitoQ

干预措施: MitoQ (Dietary Supplement)

结局指标

主要结局

Muscle mitoquinone mesylate concentration

时间窗: 5 hours after oral administration of MitoQ

Concentration of mitoquinone mesylate in skeletal muscle

次要结局

  • Blood mitoquinone mesylate concentration(Before as well as 0.5, 1, 1.5, 2, 3, 4 and 5 hours after oral administration of MitoQ)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Morten Hostrup, PhD

Associate Professor

University of Copenhagen

研究点 (1)

Loading locations...

相似试验

Concentration of MitoQ in Human Skeletal Muscle | 临床试验